Skip to podcast content

GLP-1 Hub Podcast

GLP-1s and Cancer Care: Nutrition, Symptoms and Follow-Up

By the GLP-1 Hub editorial teamArticle published With Dana Fryer, RDEpisode released June 30, 2025

Dietitian Dana Fryer explains why eating, strength and symptoms need attention when GLP-1 treatment overlaps with cancer care or recovery.

Listen to this episode

The GLP-1 Hub Podcast

Open episode on Buzzsprout

If you are receiving cancer care and taking a GLP-1, a falling weight does not tell the whole story. It matters whether you can eat enough, stay hydrated, maintain function and tolerate treatment. Intentional weight management and unwanted weight loss from illness or poor intake are different problems, even when they look similar on a scale.

Registered dietitian Dana Fryer brings that distinction to her conversation with Ana Reisdorf. Her practice includes both weight management and oncology nutrition. She describes helping people who already have a prescription work out what they can eat, when symptoms need attention and how to communicate with the clinicians managing their care.

Start by asking what the nutrition goal is now

Fryer describes two very different oncology referrals. Some people need help because cancer or treatment puts them at risk of malnutrition and unwanted weight loss. Others are referred for weight management while also receiving cancer care. She has seen a small number of patients taking GLP-1 medicines during treatment, particularly people with breast or prostate cancer.

That experience does not establish that intentional weight loss is appropriate for every person with those diagnoses, or that a GLP-1 improves cancer survival. The type and stage of cancer, treatment, symptoms and nutrition status all change the decision. The oncology team and prescribing clinician need to agree on the goal rather than assuming that the usual weight-loss target still applies.

The ASCO guideline on exercise, diet and weight management during active cancer treatment found insufficient evidence to recommend for or against intentional weight-loss interventions to improve cancer control, treatment toxicity or quality of life. That is an evidence gap, not proof of benefit or a prohibition on every individualized plan. It also is not a trial establishing GLP-1 safety during chemotherapy.

Ask your team to state the present goal plainly: maintaining weight, addressing unwanted loss or managing a weight-related condition. Ask what would lead them to reconsider it. The answer can change as treatment and recovery change.

Eating very little is a problem to discuss, not a result to celebrate

Fryer sees wide differences in appetite and tolerability. One person can eat regular meals comfortably; another feels nauseous after a sip of water. She worries when someone accepts low energy and inability to eat because the medicine appears to be producing weight loss.

Her follow-up questions are practical: How do you feel? What can you eat? Do some days or foods go better than others? A person who is having only a bite or two and feeling unwell all day needs more than encouragement to stay the course.

The National Cancer Institute’s guidance on weight changes describes how cancer treatment can affect appetite and eating through nausea, bowel changes, early fullness, mouth symptoms and fatigue. It recommends discussing appetite loss and weight loss with the care team. Adding another appetite-affecting medicine makes it especially important that the team knows what is happening; it does not make the cause of a symptom obvious.

A useful record can be simple: foods and fluids you managed, symptoms that stopped you eating and changes in energy or daily activity. You do not need to arrive with a perfect food diary. The purpose is to help your clinicians see a pattern and respond.

Small amounts of food still need to meet real needs

Fryer often starts with education about protein and nutrient density. People may recognise a food as a protein source without realising how much they are getting across the day. When the amount you can comfortably eat is small, that gap becomes more important.

She gives an example of someone who wants a large salad but feels full after a few bites. Her approach is to experiment with forms that take up less volume, such as cooked vegetables, vegetables incorporated into a sauce or a smoothie. The goal is to fit variety alongside protein, rather than let one bulky food crowd out everything else.

These are options to discuss with a dietitian, not a cancer diet that suits everyone. Mouth symptoms, swallowing problems, bowel symptoms and treatment requirements can alter what is appropriate. Some people need more concentrated nutrition or other support. Do not choose a low-calorie product simply because its packaging says it is suitable for GLP-1 users; your present needs may be different.

Fryer also describes using smaller, more frequent eating opportunities, while recognising that tolerability varies. The useful test is whether the approach helps you meet your needs and feel better. It is not whether you can make portions as small as possible.

Muscle loss and cachexia need their own assessment

Ana asks why weight loss would ever be a goal in cancer care, given the concern about wasting. Fryer explains that you cannot reliably distinguish intentional loss from harmful poor intake just by looking at someone. A nutrition assessment helps identify what is driving the change and what support is needed.

Cancer cachexia is also not simply another name for eating too little. The National Cancer Institute describes it as a wasting syndrome involving muscle and fat loss that cannot be reversed by nutrition support alone. Weakness, fatigue and weight loss can have several causes, so a reader should not self-diagnose cachexia or assume that a protein drink will resolve it.

Tell your team if daily tasks are becoming harder, your strength is changing or you cannot maintain intake. A higher starting weight does not make those changes unimportant. For a separate discussion about beginning movement at an appropriate level, read Aaron Hines’s approach to individualized strength training.

Bring supplements into the medication review

Fryer is especially cautious about supplements in oncology care. She works with pharmacists to check potential interactions and points out how many new products are marketed for GLP-1 users. A promise of energy or nutritional support does not show that a product is suitable alongside a particular cancer treatment.

NCI guidance on food and supplement interactions explains that supplements, herbs and other products can change how cancer medicines work in the body. Take the actual product names and ingredient lists to your oncology team or pharmacist, including multivitamins and drinks with added ingredients.

This is not a reason to assume every supplement is forbidden or that everyone needs one. It is a reason to have your own treatment and nutrition needs checked before adding a product. The person evaluating it needs to know both what you are taking and why.

Make it easier to tell the prescriber when something is wrong

Fryer describes patients who hesitate to report symptoms because they fear losing a prescription or insurance coverage. Getting treatment may have taken so much effort that asking for a change feels risky. That anxiety can leave low intake, nausea and fatigue unaddressed.

She helps patients prepare questions for follow-up and sometimes contacts the prescriber with a nutrition update. Her role is not to adjust medication herself. It is to make the clinical conversation more informed and help the patient describe what is actually happening.

Ask who to contact if eating or drinking becomes difficult, how soon concerns will be reviewed and how the oncology and prescribing teams will communicate. Access problems deserve help, but they should not require hiding symptoms or improvising a dose change. Dr. Andrew Shapiro’s discussion of GLP-1s after breast cancer considers another part of that shared-care relationship.

Recovery goals should fit the person’s capacity

After treatment, Fryer sees people dealing with weight changes, fatigue and the practical work of rebuilding routines. Some feel ready to focus on meals and activity; others have already been asked to manage more than they can comfortably carry. She does not want nutrition counselling to become another burden.

Her approach leaves the door open: support can begin with the problem that matters now and expand when the person is ready. Better nutrition, function and follow-up are worthwhile goals without promising that weight loss prevents recurrence. A plan should help you live through treatment and recovery, not ask the scale to stand in for your overall health.